Two cases of telangiectasia macularis eruptiva perstans demonstrated by immunohistochemistry for C-Kit(CD 117)

Journal of Dermatology

Volumn 32, Issue 10, 2005, Pages 817-820

  Lee, Hae Woong ^a   Jeong, Young Il ^a   Choi, Jung Chul ^a,b   Lee, Mi Woo ^a   Choi, Jee Ho ^a   Moon, Kee Chan ^a   Koh, Jai Kyoung ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

c kit; CD117; Mastocytosis; Pimecrolimus; Telangiectasia macularis eruptiva perstans

Indexed keywords

PIMECROLIMUS; STEM CELL FACTOR RECEPTOR;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MALE; MASTOCYTOSIS; PHYSICAL EXAMINATION; TELANGIECTASIA;

EID: 28244487282     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00851.x     Document Type: Article

References (15)

1. Longley J, Duffy TP, Kohn S: The mast cell and mast cell disease, J Am Acad Dermatol, 32: 545-561, 1995.
2. Valent P, Horny HP, Escribano L, et al: Diagnostic criteria and classification of mastocytosis: A consensus proposal, Leuk Res, 25: 603-625, 2001.
3. Brownstein MH, Rabinowitz AD: The invisible dermatoses, J Am Acad Dermatol, 8: 579-588, 1983.
4. Sarkany RP, Monk BE, Hadfield-Jones SE: Telangiectasia macularis eruptiva perstans: a case report and review of the literature, Clin Exp Dermatol, 23: 38-39, 1998.
5. Hartmann K, Henz BM: Mastocytosis: recent advances in defining the disease, Br J Dermatol, 144: 682-695, 2001.
6. Fried SZ, Lynfield YL: Unilateral facial telangiectasia macularis eruptiva perstans, J Am Acad Dermatol, 16: 250-252, 1987.
7. Ellis DL: Treatment of telangiectasia macularis eruptiva perstans with the 585-nm flashlamp-pumped dye laser, Dermatol Surg, 22: 33-37, 1996.
8. Gibbs NF, Friedlander SF, Harpster EF: Telangiectasia macularis eruptiva perstans, Pediatr Dermatol, 17: 194-197, 2000.
9. Sweet WL, Smoller BR: Perivascular mast cells in urticaria pigmentosa, J Cutan Pathol, 23: 247-253, 1996.
10. Li CY: Diagnosis of mastocytosis: Value of cytochemistry and immunohistochemistry, Leuk Res, 25: 537-541, 2001.
11. Natkunam Y, Rouse RV: Utility of paraffin section immunohistochemistry for C-KJT (CD117) in the differential diagnosis of systemic mast cell disease involving the bone, Am J Surg Pathol, 24: 81-91, 2000.
12. Monahan TP, Petropolis AA: Treatment of telangiectasia macularis eruptiva perstans with total skin electron beam radiation, Cutis, 71: 357-359, 2003.
13. Zuberbier T, Chong SU, Grunow K, et al: The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils, J Allergy Clin Immunol, 108: 275-280, 2001.
14. Eichenfield LF, Beck L: Elidel (pimecrolimus) cream 1%: A nonsteroidal topical agent for the treatment of atopic dermatitis, J Allergy Clin Immunol, 111: 1153-1168, 2003.
15. Gupta AK, Chow M: Pimecrolimus: A review, J Eur Acad Dermatol Venereol, 17: 493-503, 2003.